NCT04481347

Brief Summary

The challenge of new recommendations and better adapted practices is pushing to operate patients who are getting older and more fragile. In this context, there is an inevitable increase in the risks associated with care and in particular perioperative neurological complications, of which postoperative cognitive dysfunction (POCD) is the most common. The interest of perioperative cerebral monitoring and in particular electroencephalography (EEG) to reduce neurological and cognitive damage in surgery has been the subject of abundant research and corresponds to a crucial issue. From the literature and preliminary results obtained in our clinical research unit, it appears that there is also a relationship between certain characteristics of the peroperative EEG (signal strength and burst suppression) and the occurrence of postoperative cognitive dysfunction (PCOD). In this context, quantitative analysis of the preoperative sleep EEG and the EEG obtained during general anesthesia could allow the identification of a simple to use biomarker of susceptibility or fragility. To our knowledge, there is no preoperative evaluation strategy using EEG analysis to detect a predisposition to POCD. The main goal of this observational clinical study is to extend the traditional use of per-operative EEG with pre-operative and post-operative sleep EEG for the detection and prediction of early post-operative cognitive dysfunction.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 23, 2020

Completed
22 days until next milestone

Study Start

First participant enrolled

July 15, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 22, 2020

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

October 25, 2023

Status Verified

October 1, 2023

Enrollment Period

3.9 years

First QC Date

June 23, 2020

Last Update Submit

October 24, 2023

Conditions

Keywords

postoperative cognitive dysfunctiondepth of anesthesiabrain fragilityelectrographic suppression

Outcome Measures

Primary Outcomes (1)

  • Early postoperative cognitive dysfunction

    Score obtained following evaluation of the patient's cognitive function using the Montreal Cognitive Assessment questionnaire MoCA (0-30; higher score indicates better performance)

    Change between day -1 and day 5

Secondary Outcomes (4)

  • Burst suppression duration

    Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)

  • Variations in alpha power on sleep EEG

    Change between day -1 and day 5

  • Spindle amplitude on sleep EEG

    Change between day -1 and day 5

  • Spindle frequency on sleep EEG

    Change between day -1 and day 5

Study Arms (1)

Patients undergoing general anesthesia

Patients eligible for interventional neuroradiology or surgery performed under general anesthesia. Patients will be included if they are admitted for a non-emergency scheduled procedure.

Device: Sleep EEG recording using a DREEM® headbandOther: Montreal Cognitive Assessment (MoCA)Device: Intraoperative EEG recording using a Sedline® monitoring

Interventions

Sleep EEG recording using a Dreem® headband (Rythm, Paris, France), an EEG recording device adapted to sleep conditions and completely non-invasive

Patients undergoing general anesthesia

Neuropsychological assessment using the The Montreal Cognitive Assessment (MoCA) questionnaire to detect postoperative cognitive dysfunction

Patients undergoing general anesthesia

Intraoperative brain function monitoring using a Sedline® module (Masimo corporation) to evaluate the state of the brain under anesthesia

Patients undergoing general anesthesia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients eligible for a non-emergency scheduled interventional neuroradiology procedure or surgery performed under general anesthesia.

You may qualify if:

  • Major patients (≥ 18 years )
  • Eligible for an interventional radiology procedure or surgery under general anesthesia
  • Patients informed and having expressed their non-opposition to participation in this research

You may not qualify if:

  • Patients under 18 years old
  • Severe pre-existing cognitive impairment (preoperative mini-mental state examination (MMSE) \< 24)
  • Patient opposed to protocol participation
  • Pregnant woman
  • Patient under judicial protection
  • Patient without affiliation to a social security scheme
  • Emergency procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AP-HP, Lariboisière Hospital, Department of Anesthesiology and Intensive Care

Paris, 75010, France

RECRUITING

MeSH Terms

Conditions

Postoperative Cognitive Complications

Interventions

Mental Status and Dementia Tests

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsCognitive DysfunctionCognition DisordersNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Neuropsychological TestsPsychological TestsBehavioral Disciplines and Activities

Study Officials

  • Joaquim MATEO, MD

    Assistance Publique - Hôpitaux de Paris

    STUDY DIRECTOR
  • Fabrice VALLEE, MD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 23, 2020

First Posted

July 22, 2020

Study Start

July 15, 2020

Primary Completion

June 1, 2024

Study Completion

June 1, 2024

Last Updated

October 25, 2023

Record last verified: 2023-10

Locations